Treating Cancer with Clay Siegel’s Approach

Contemporary cancer treatment breakthrough

Cancer being one of the diseases known to have a high mortality rate has led to the desperate moves by medical practitioners to find ways of controlling it. Some of the most revolutionary scientific methods have actually been employed in the fight against this atrocious disease. Such methods include the use of antibody-based therapies in pursuit of optional treatments for it. As new treatments for cancer develop, Antibody Drug Conjugates is the best known effective approach in cancer treatment. This is mainly because the approach targets specific conditions with uttermost power. Therefore, the drug-based research on cancer treatment remains one of the most promising approaches in the global fight against this feared condition.

Siegall significance in the advancement of cancer treatment

In regard to the search for a solution to cancer which the world faces in the 21st century, Clay Siegall has been on the forefront to fight back. He is the CEO and chairman of Seattle Genetics, a well reputable and globally acclaimed champion in the fight against cancer. He founded the company in 1998 and became its first CEO and chairman of the board. Due to his exemplary innovative ideas, he was awarded the accelerated approval by FDA in the year 2011. The US Food and Drug Authority deemed it fit to have the Ph.D. holder approved to deal with issues touching on genetics.

  1. Clay Siegall attained his Ph.D. in genetics from the Gorge Washington University. This was after graduating with a Bachelor of Science in Zoology from the University of Maryland. The good doctor has been in the industry for long gathering information and experience over the years. This has enabled him to develop more than 50 publications while holding patents to at least 15 of them. He was behind the $657 million public/private financing of his company in the year 2001. Long before he founded his company, Dr. Siegall had a long career of close to a decade at the Bristol-Myers Squibb Pharmaceutical Research institute.
Treating Cancer with Clay Siegel’s Approach